Market Insight - Pharma sector in Turkey to shrink 25% under tough conditions
This article was originally published in Scrip
Executive Summary
The pharmaceutical industry has long eyed Turkey as one of its key emerging markets, but recent government action, which could see medicine access delayed by years, is giving it a wake-up call, Elizabeth Sukkar, Scrip's world editor, reports.